UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of KRAS mutations on clinical outcome in patients with curatively resected stage III colon cancer treated with adjuvant chemotherapy

European review for medical and pharmacological sciences, 2020-03, Vol.24 (6), p.2994

2020

Volltextzugriff (PDF)

56P Prevalence, clinical characteristics, and treatment outcomes of patients with KRAS-mutated non-squamous NSCLC and PD-L1 expression: Real-life data analysis

ESMO open, 2024-03, Vol.9, p.102635, Article 102635

2024

Volltextzugriff (PDF)

Functional and clinical significance of ROR1 in lung adenocarcinoma

BMC cancer, 2020-11, Vol.20 (1), p.1085-1085, Article 1085

2020

Volltextzugriff (PDF)

A qPCR technology for direct quantification of methylation in untreated DNA

Nature communications, 2023-08, Vol.14 (1), p.5153-5153, Article 5153

2023

Volltextzugriff (PDF)

One-instrument, objective microsatellite instability analysis using high-resolution melt

PloS one, 2024-04, Vol.19 (4), p.e0302274-e0302274

2024

Volltextzugriff (PDF)

Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3

PloS one, 2017-10, Vol.12 (10), p.e0187289-e0187289

2017

Volltextzugriff (PDF)

Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers

Cancers, 2022-08, Vol.14 (17), p.4103

2022

Volltextzugriff (PDF)

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer

Journal of clinical medicine, 2022-12, Vol.11 (24), p.7523

2022

Volltextzugriff (PDF)

Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen® FFPE BRAF qPCR assay

PloS one, 2023-02, Vol.18 (2), p.e0281558-e0281558

2023

Volltextzugriff (PDF)

A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies

PloS one, 2021-06, Vol.16 (6), p.e0253687-e0253687

2021

Volltextzugriff (PDF)

Overview of recent advances in molecular analysis for diagnosing early stage lung cancer nodules

Translational lung cancer research, 2021-11, Vol.10 (11), p.4303-4307

2021

Volltextzugriff (PDF)

Correction to: Functional and clinical significance of ROR1 in lung adenocarcinoma

BMC cancer, 2020-12, Vol.20 (1), p.1-1196, Article 1196

2020

Volltextzugriff (PDF)

Antiandrogens as Therapies for COVID-19: A Systematic Review

Cancers, 2024-01, Vol.16 (2), p.298

2024

Volltextzugriff (PDF)

Role of NEU3 Overexpression in the Prediction of Efficacy of EGFR-Targeted Therapies in Colon Cancer Cell Lines

International journal of molecular sciences, 2020-11, Vol.21 (22), p.8805

2020

Volltextzugriff (PDF)

The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation

Frontiers in oncology, 2020-01, Vol.9, p.1569-1569

2020

Volltextzugriff (PDF)

Research progress on KRAS mutations in colorectal cancer

Journal of Cancer Metastasis and Treatment, 2021

2021

Volltextzugriff (PDF)

CT evaluation of lung infiltrates in the two months preceding the Coronavirus disease 19 pandemic in Canton Ticino (Switzerland): were there suspicious cases before the official first case?

Radiologia medica, 2022-04, Vol.127 (4), p.360-368

2022

Volltextzugriff (PDF)

Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy

Journal of clinical medicine, 2022-03, Vol.11 (6), p.1627

2022

Volltextzugriff (PDF)

Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen.sup.® FFPE BRAF qPCR assay

PloS one, 2023-02, Vol.18 (2), p.e0281558

2023

Volltextzugriff (PDF)

Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis

Cells (Basel, Switzerland), 2024-02, Vol.13 (3), p.276

2024

Volltextzugriff (PDF)

The role of Piccolo in cancer treatment: relationship with EGFR and related therapies, and a marker for new targeted therapies

Journal of thoracic disease, 2017-11, Vol.9 (11), p.4240-4243

2017

Volltextzugriff (PDF)

SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations

PloS one, 2017-06, Vol.12 (6), p.e0178027-e0178027

2017

Volltextzugriff (PDF)

Non-small cell lung cancer

PloS one, 2017-10, Vol.12 (10), p.e0187289

2017

Volltextzugriff (PDF)

Identification of MGMT Downregulation Induced by miRNA in Glioblastoma and Possible Effect on Temozolomide Sensitivity

Journal of clinical medicine, 2023-03, Vol.12 (5), p.2061

2023

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of KRAS mutations on clinical outcome in patients with curatively resected stage III colon cancer treated with adjuvant chemotherapy

56P Prevalence, clinical characteristics, and treatment outcomes of patients with KRAS-mutated non-squamous NSCLC and PD-L1 expression: Real-life data analysis

Functional and clinical significance of ROR1 in lung adenocarcinoma

A qPCR technology for direct quantification of methylation in untreated DNA

One-instrument, objective microsatellite instability analysis using high-resolution melt

Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3

Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer

Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen® FFPE BRAF qPCR assay

A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies

Overview of recent advances in molecular analysis for diagnosing early stage lung cancer nodules

Correction to: Functional and clinical significance of ROR1 in lung adenocarcinoma

Antiandrogens as Therapies for COVID-19: A Systematic Review

Role of NEU3 Overexpression in the Prediction of Efficacy of EGFR-Targeted Therapies in Colon Cancer Cell Lines

A Pilot, Prospective, Observational Study to Investigate the Value of NGS in Liquid Biopsies to Predict Tumor Response After Neoadjuvant Chemo-Radiotherapy in Patients With Locally Advanced Rectal Cancer: The LiBReCa Study

The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation

Research progress on KRAS mutations in colorectal cancer

CT evaluation of lung infiltrates in the two months preceding the Coronavirus disease 19 pandemic in Canton Ticino (Switzerland): were there suspicious cases before the official first case?

Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy

Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen.sup.® FFPE BRAF qPCR assay

Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis

The role of Piccolo in cancer treatment: relationship with EGFR and related therapies, and a marker for new targeted therapies

SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations

Non-small cell lung cancer

Identification of MGMT Downregulation Induced by miRNA in Glioblastoma and Possible Effect on Temozolomide Sensitivity

Suchergebnisse filtern